Brief: Chemomab Therapeutics Announces Third Quarter 2021 Financial Results
12/11/2021 12:35
Nov 12 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CHEMOMAB THERAPEUTICS ANNOUNCES THIRD QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
* Q3 LOSS PER SHARE $0.01
* EXISTING CASH POSITION IS EXPECTED TO FUND COMPANY'S
CURRENT
OPERATING PLAN UNTIL MID-2023
Source text for Eikon: ID:nPn1mS0vma
Further company coverage: CMMB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update